Health Care & Life Sciences » Pharmaceuticals | BioSyent Inc.

BioSyent Inc.

BioSyent Inc.
Stock Exchange Other OTC
EPS
 $0.29
Market Cap
 $67.79 M
Shares Outstanding
 14.52 M
Public Float
 -
BioSyent Inc.
Stock Exchange Toronto Ventures Stock Exchange
EPS
 CAD0.38
Market Cap
 CAD88.82 M
Shares Outstanding
 13.84 M
Public Float
 11.35 M

Profile

Address
170 Attwell Drive
Toronto Ontario M9W 5Z5
Canada
Employees -
Website http://www.biosyent.com
Updated 07/08/2019
BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System, and Cysview. The company was founded on April 28, 1947 and is headquartered in Ontario, Canada.

Financials

View All
Created with Highcharts 5.0.14BioSyent Inc.Net Income. Fiscal year is January-December. All values CAD Thousands.1 9281 9283 1543 1543 7643 7644 3094 3095 2065 2065 7055 70520132014201520162017201801k2k3k4k5k6k
Created with Highcharts 5.0.14BioSyent Inc.Sales/Revenue. Fiscal year is January-December. All values CAD Thousands.7 7997 79912 21112 21115 38815 38817 92217 92220 76220 76221 52721 52720132014201520162017201805k10k15k20k25k

René C. Goehrum
Chairman, President & Chief Executive Officer
Joseph Arcuri
Independent Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.